Search Results - "Danis, Ryan"

Serum B-Cell Maturation Antigen Reflects Disease Status in a Patient Who Developed Nonsecretory Multiple Myeloma: A Case Report by Danis, Ryan, Regidor, Bernard, Bujarski, Sean, Jew, Scott, Goldwater, Marissa-Skye, Swift, Regina, Eades, Benjamin Mark, Emamy-Sadr, Marsiye, Del Dosso, Ashley, Berenson, James

“…Multiple myeloma (MM) is an incurable bone marrow (BM)-based cancer involving clonal plasma cells. Most patients show elevated levels of serum monoclonal…”
Get full text

Outcomes of Triple Class Refractory Multiple Myeloma Patients: A Single Center Retrospective Study by Danis, Ryan, Yashar, David, Bujarski, Sean, Jew, Scott, Swift, Regina, Berenson, James R

“…BACKGROUND Despite recent advances in the treatment of multiple myeloma (MM), the disease remains incurable. Recent studies suggest that patients who are…”
Get full text

Medical Writing Bias in Myeloma Clinical Research: A Comprehensive Analysis by ElSayed, Adam, Mettias, Sarah, Kim, Susanna, Danis, Ryan, Berenson, James R

“…Background Previous studies investigating associations between pharmaceutical funding and clinical trial results have found ties between pharmaceutical…”
Get full text

Efficacy of isatuximab in combination with steroids for the treatment of relapsed/refractory multiple myeloma patients exhibiting only biochemical progression-A single center retrospective study by Regidor, Bernard Sean, Jew, Scott, Goldwater, Marissa-Skye, Beatty, Bethany Marie, Bujarski, Sean, ElSayed, Adam, Danis, Ryan, Kim, Susanna, Swift, Regina, Schwartz, Gary, Berenson, James R

“…Isatuximab is approved for treatment of relapsed/refractory multiple myeloma (RRMM) with dexamethasone and carfilzomib or pomalidomide. Patients receiving…”
Get full text